Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 226.00
Bid: 225.50
Ask: 226.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.443%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 226.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling

Tue, 16th Apr 2024 21:57

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value was 39.7 pence per share at February 29, down from 45.3 pence at February 28, 2023. Chair says: "In a year when the FTSE AIM All Share Index declined by 14%, your company made a loss of GBP1.75 million with net assets down by 19%" and that this year's results "can only be described as disappointing". Declares 55.0p dividend for the year to February 29, unchanged from the year before. Says it now has "the critical mass we have been seeking for a long time", and that it is currently seeking alternative plans to manage its rump portfolio once its primary assets have been realised.

----------

Petra Diamonds Ltd - Bermuda-based diamond mining group - Says revenue for the third quarter of financial 2024 totalled USD66 million, down from USD90 million in the second quarter. Says the decrease was due to lower production and the timing of receipts from Tender 5. Says this fifth tender cycle yielded USD49 million from the sale of 362,132 carats at an average price of USD136 per carat. This compares with USD48 million from 428,860 carats at USD112 per carat in the fourth tender cycle. Says production for the quarter was consistent with the preceding three months and in line with expectations. Total tonnes treated decreased 1.5% to 2.9 million tonnes from 3.0 million tonnes.

----------

J Smart & Co (Contractors) PLC - Edinburgh-based construction contractor - Pretax profit for the six months to January 31 falls 21% to GBP205,000 from GBP260,000 the year before. Revenue however rises 54% to GBP8.6 million from GBP5.6 million. Company declares 0.96p per share interim dividend, unchanged year-on-year. Cost of sales rises to GBP6.4 million from GBP2.1 million. Company says construction material prices "are still rising, which continues to affect the viability of all types of potential projects". Says there has been a "slight improvement" on limited reservations compared to in late 2023, but continuing economic issues are still affecting consumer sentiment. Says lettings remain "robust" but that in the year to July 31 "there will definitely be profit erosion due to lack of external contracts, the lack of recovery of overhead costs, the continued increase in material costs, prolonged programmes due to utility infrastructure and statutory authority delays and the cost of holding private housing stock".

----------

Tertiary Minerals PLC - mineral development company focused on deposits in the US, Zambia and Northern Europe - Announces that drilling is now underway at the Konkola West Copper Project in Zambia. The project "is targeting projected deep down-dip and along-strike extensions of the contiguous Lubambe-Mingomba-Konkola copper deposits to the east of the licence and which extend north into the Musoshi mining complex in the Democratic Republic of the Congo". The long continuous zone of mineralisation is 15 kilometres total and contained a pre-mining endowment of over 775 million tonnes of copper graded at between 2% and 3%.

----------

PureTech Health PLC - London-based biotherapeutics company - Completes enrolment in the Elevate IPF Phase 2b clinical trial, which will evaluate LYT-100 or deupirfenidone in patients with idiopathic pulmonary fibrosis or IPF. Says LYT-100 is a deuterated form of pirfenidone, one of the two standard-of-care treatments approved to treat IPF. The randomised double-blind trial will measure as primary endpoint the rate of decline in forced vital capacity for the combined LYT-100 arms versus the placebo group over 26 weeks. Says other key endpoints will include tolerability measures, biomarkers and patient-reported outcomes. Expects topline results in the fourth quarter of 2024.

----------

DP Poland PLC - London-based operator of Domino's pizza stores and restaurants in Poland and Croatia - Raises gross GBP1 million pursuant to oversubscribed retail offer, with 10.1 million shares to be issued as a result. Says it has raised around GBP20.5 million in total from subscription, placing and retail offer combined. Fundraise was announced in late March, with placing price of 9.92p per share. This included a GBP11 million investment from Domino's Pizza Group PLC.

----------

Golden Metal Resources PLC - Nevada-focused metals exploration company - Says ground magnetic survey has detected significant anomalies at its Garfield project in Nevada's Walker Lane Mineral Belt. Says two magnetic anomalies were detected within the 'High-Grade' zone, and another was located in the southwestern part of the 'Power-Line' zone. Says it is "very encouraged" by the results, and has commissioned a ground magnetic geophysics survey across some of the main target areas at Pilot Mountain. Results are currently being processed. Adds that drilling preparations for Pilot Mountain are "well underway" and expects to receive permits "imminently". Chief Executive Officer Oliver Friesen says 2024 "is shaping up to be a very exciting year for Golden Metal", which is "positioned perfectly to address" the increasing demand for "important metals such as tungsten".

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
19 Mar 2024 11:16

PureTech shares jump on USD100 million tender offer proposal

(Alliance News) - PureTech Health PLC on Tuesday said it plans to return USD100 million to shareholders with a tender offer, starting after it publishes its annual report in April.

Read more
19 Mar 2024 09:46

Puretech Health proposes $100m capital return

(Sharecast News) - Biotherapeutics company PureTech Health has proposed a capital return of $100.0m to its shareholders by way of a tender offer.

Read more
13 Mar 2024 12:27

PureTech Health celebrates drug designation for LYT-200 from US FDA

(Alliance News) - PureTech Health PLC on Wednesday touted the efficacy of its acute myeloid leukaemia therapy, after securing a regulatory designation from the US Food & Drug Administration.

Read more
27 Feb 2024 11:28

PureTech notes positive results from Shionogi's EndeavorRx ADHD trial

(Alliance News) - PureTech Health PLC on Tuesday noted that its founded entity, Akili Inc, has announced positive results from a phase 3 clinical trial of EndeavorRx for children with attention deficit hyperactivity disorder in Japan.

Read more
20 Dec 2023 09:53

PureTech makes strong progress, expects "multiple catalysts" next year

(Alliance News) - PureTech Health PLC on Wednesday said it made "strong strategic and clinical progress" in 2023, and predicted "a productive and exciting" tear to come.

Read more
1 Dec 2023 14:29

TRADING UPDATES: N4 launches investor hub; Capricorn production falls

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:

Read more
17 Nov 2023 09:44

IN BRIEF: PureTech hails schizophrenia trial results for Karuna drug

PureTech Health PLC - Boston, Massachusetts-based FTSE 250 biotechnology company - Founded entity Karuna Therapeutics reports "positive results" from Phase 1b trial evaluating the effects of xanomeline-trospium, brand name KarXT, on 24-hour ambulatory blood pressure in adults with schizophrenia. Karuna says KarXT does not cause clinically meaningful blood pressure increases, with an average change from baseline at week eight of minus 0.59 mmHg or millimetre of mercury. Other vital signs like average diastolic blood pressure and heart rate were consistent with previous KarXT trials in schizophrenia. Adds that KarXT was generally well-tolerated, and side effects remained consistent with prior trials under the Emergent programme. Karuna in late September announced its application to the US Food & Drug Administration for approval of KarXT to treat schizophrenia; if successful, it will be PureTech's third therapeutic candidate to gain FDA approval. KarXT is also in development to treat psychosis associated with Alzheimer's disease.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
14 Nov 2023 10:59

PureTech Health celebrates positive results in Phase 2 anxiety trial

(Alliance News) - PureTech Health PLC on Tuesday said its therapeutic LYT-300 achieved its primary endpoint for acute anxiety reduction, in a Phase 2a trial using healthy volunteers.

Read more
11 Oct 2023 14:22

IN BRIEF: PureTech's LYT-100 shows 50% improvement to key adverse events

PureTech Health PLC - Boston-based biotechnology company - Says LYT-100 trial shows around 50% improvement in gastrointestinal and central nervous system related adverse events in adults suffering from idiopathic pulmonary fibrosis compared to US Food & Drug Administration-approved pirfenidone. Adds data shows higher dose of LYT-100 well-tolerated with no additional incidence of GI or CNS AEs when titrated up from 550 milligrams dosage.

Read more
4 Oct 2023 13:55

PureTech Health subsidiary receives fast track designation for VE202

(Alliance News) - PureTech Health PLC on Wednesday said its subsidiary Vedanta Biosciences has received fast-track designation for its VE202 treatment.

Read more
28 Sep 2023 15:08

TRADING UPDATES: Rockhopper loss widens; Synectics inks new contract

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Sep 2023 10:40

Arix Bioscience boosts net value, CEO jumping ship for PureTech Health

(Alliance News) - Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review due to "unfavourable" conditions while Chief Executive Officer Robert Lyne prepares to step down.

Read more
29 Aug 2023 09:39

PureTech narrows interim loss despite "stormy market challenges"

(Alliance News) - PureTech Health PLC on Tuesday said its half-year loss narrowed, but saw its revenue fall by more than half.

Read more
29 Aug 2023 09:03

LONDON MARKET OPEN: FTSE 100 catches up with bank holiday rally

(Alliance News) - Stock prices in London opened higher on Tuesday, as UK markets return from a long bank holiday weekend and news that UK shop price inflation decelerated in August.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.